Structure and mechanism of the rebeccamycin sugar 4'-O-methyltransferase RebM.
Shanteri Singh, Jason G McCoy, Changsheng Zhang, Craig A Bingman, George N Phillips, Jon S Thorson
Index: J. Biol. Chem. 283(33) , 22628-36, (2008)
Full Text: HTML
Abstract
The 2.65-angstroms crystal structure of the rebeccamycin 4'-O-methyltransferase RebM in complex with S-adenosyl-l-homocysteine revealed RebM to adopt a typical S-adenosylmethionine-binding fold of small molecule O-methyltransferases (O-MTases) and display a weak dimerization domain unique to MTases. Using this structure as a basis, the RebM substrate binding model implicated a predominance of nonspecific hydrophobic interactions consistent with the reported ability of RebM to methylate a wide range of indolocarbazole surrogates. This model also illuminated the three putative RebM catalytic residues (His140/141 and Asp166) subsequently found to be highly conserved among sequence-related natural product O-MTases from GC-rich bacteria. Interrogation of these residues via site-directed mutagenesis in RebM demonstrated His140 and Asp166 to be most important for catalysis. This study reveals RebM to be a member of the general acid/base-dependent O-MTases and, as the first crystal structure for a sugar O-MTase, may also present a template toward the future engineering of natural product MTases for combinatorial applications.
Related Compounds
Related Articles:
Natural product diversification using a non-natural cofactor analogue of S-adenosyl-L-methionine.
2006-03-08
[J. Am. Chem. Soc. 128(9) , 2760-1, (2006)]
Engineering biosynthetic pathways to generate antitumor indolocarbazole derivatives.
2006-07-01
[J. Ind. Microbiol. Biotechnol. 33(7) , 560-8, (2006)]
2006-06-27
[Biochemistry 45(25) , 7904-12, (2006)]
Rebeccamycin derivatives as dual DNA-damaging agents and potent checkpoint kinase 1 inhibitors.
2008-12-01
[Mol. Pharmacol. 74(6) , 1620-9, (2008)]
2009-10-01
[Mol. Biosyst. 5(10) , 1180-91, (2009)]